Bachem Holding AG
BANB
株式のランク
#2525
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
株価
$100.24
時価総額
$7.51B
変化（1日）
-1.84%
変化（1年）
48.99%
国
CH
取引 Bachem Holding AG (BANB)
カテゴリー
Healthcare
Bachem Holding AG（BANB）の株価履歴
終値の最高値: $105.12 （2026-10-01）
終値の最安値: $13.47 （2001-03-01）
終値の最安値: $13.47 （2001-03-01）
Bachem Holding AG の株価履歴（2001 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 26.87% |
| 2025 | -3.05% |
| 2024 | -5.47% |
| 2023 | -16.69% |
| 2022 | -35.59% |
| 2021 | 68.81% |
| 2020 | 169.92% |
| 2019 | 28.96% |
| 2018 | -16.46% |
| 2017 | 68.14% |
| 2016 | 64.94% |
| 2015 | 3.94% |
| 2014 | -8.15% |
| 2013 | 45.10% |
| 2012 | -0.04% |
| 2011 | -34.01% |
| 2010 | -12.09% |
| 2009 | -5.58% |
| 2008 | -20.36% |
| 2007 | 13.73% |
| 2006 | 32.09% |
| 2005 | 1.28% |
| 2004 | 12.61% |
| 2003 | 11.00% |
| 2002 | -19.59% |
| 2001 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $535.81 | 25.65% |
US
|
|
| $188.41 | 601.69% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $890.95 | 9.43% |
NL
|
